News & Analysis - CNBC

1. Brent crude nears $100 after strikes on Saudi energy sites amid renewed Mideast hostilities

2. Bombardier points out U.S. footprint after Trump says aerospace giant must build in America

3. AstraZeneca's COPD drug scores two late-stage trial wins as full data boosts blockbuster hopes

4. Visa tells CNBC it is expanding data offering for blockchain lenders as demand for stablecoin-linked cards surges

5. Canada's retaliatory tariffs worth $27.6 billion take effect as trade rift with U.S. deepens

6. Pharma major Novartis falls 9% after three drug trial setbacks

7. Santoli: One key tech ETF may signal whether this bull market can keep marching on

8. The U.S. is trying to reduce its reliance on China for batteries. Here's what it's up against

9. Cholesterol drug setback casts doubt over multibillion-dollar race 

10. Global markets keep shrugging off shocks. Here's what could break that streak, according to HSBC

11. Australia to let social media users 'opt out' of algorithm-based feeds in fresh blow to big tech

12. TSMC, Samsung commit to ASML’s newest chipmaking tools as AI drives demand

13. SpaceX rival launches rocket in historic first, says industry is 'desperate' for more

14. Trump says he's made 'Hundreds of Billions of Dollars on Stocks' for the U.S., in stream of AI posts

15. Here are the 3 big things we're watching in this holiday-shortened trading week

16. SEC sues ISS as Trump administration ramps up scrutiny of proxy advisers

17. Jaguar Land Rover to cut 4,000 jobs over two years in major cost-saving drive

18. It's been a rough month of natural disasters. Here's a review of some of the worst

19. Crypto platforms have lost over $3.63 billion to cyberattacks — even though most of them did security checks

20. ‘Model fatigue’ sets in as AI labs race to roll out new versions at frenetic pace